Two-year changes of bone mineral density in steroid-treated myasthenia gravis
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Bone and Mineral Metabolism"
DOI: 10.1007/s00774-020-01181-3
Abstract: In addition to bisphosphonates, eldecalcitol is effective for the prevention of glucocorticoid-induced osteoporosis (GIO) [1]. Several strategies for avoiding GIO have been developed. Although steroids are a principal therapy for myasthenia gravis (MG), GIO reduces… read more here.
Keywords: bone mineral; treatment; year; gio ... See more keywords
Diet-induced- and genetic- obesity differentially alters male germline histones.
Sign Up to like & getrecommendations! Published in 2021 at "Reproduction"
DOI: 10.1530/rep-21-0034
Abstract: Obesity, an established risk factor for male subfertility or infertility, is primarily due to genetic and environmental causes. Our earlier studies have shown differential effects of high fat diet-induced- (DIO) and genetically inherited- (GIO) obesity… read more here.
Keywords: obesity; gio; histone; male germline ... See more keywords
Tanshinol Alleviates Microcirculation Disturbance and Impaired Bone Formation by Attenuating TXNIP Signaling in GIO Rats
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2021.722175
Abstract: Impaired bone formation is the main characteristics of glucocorticoid (GC)-induced osteoporosis (GIO), which can be ameliorated by tanshinol, an aqueous polyphenol isolated from Salvia miltiorrhiza Bunge. However, the underlying mechanism is still not entirely clear.… read more here.
Keywords: impaired bone; txnip signaling; gio rats; bone ... See more keywords